ArticleInternal medicine (Tokyo, Japan)2025
Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease.
Takashi Ozaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.